Pneumococcal Pyopericardium With Xiphoid Osteomyelitis in HIV/AIDS: A Rare but Potentially Fatal Complication

Nihar Jena1, Izza Saeed1, Mackenzie Hamilton1

  • 1Department of Interventional Cardiology, Marshall University, Huntington, West Virginia, USA.

PubMed

Insights

Purulent pericarditis, a rare infection, can occur in immunocompromised patients. This case highlights successful management of pneumococcal pyopericardium with cardiac tamponade in an HIV patient.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Purulent pericarditis is a rare but life-threatening infection, increasingly seen in immunocompromised individuals.
  • Antibiotic use has reduced its incidence, but opportunistic infections remain a risk.
  • It often arises from secondary bacterial spread.

Observation:

  • A 55-year-old man with HIV cardiomyopathy presented with chest pain and dyspnea.
  • Initial cardiac catheterization showed normal coronary arteries, but echocardiography revealed pericardial effusion with tamponade.
  • Pericardial fluid analysis identified Streptococcus pneumoniae.

Findings:

  • The patient required pericardiocentesis and later a subxiphoid pericardial wash due to reaccumulating effusion.
  • A concurrent diagnosis of acute osteomyelitis of the xiphoid was made.
  • Treatment involved antibiotics and drainage procedures.

Implications:

  • This case underscores the risk of opportunistic infections like pneumococcal pyopericardium in HIV patients, even with antiretroviral therapy.
  • Prompt diagnosis and multidisciplinary management are crucial for improving outcomes in this rare condition.
  • It highlights advancements in managing purulent pericarditis with tamponade.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
329
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
435
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
549
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
355
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
447